5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole

Public-database records for 5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (CAS 906673-24-3), reproduced here for independent cross-checking.

Safety classification and hazard statements

Regulatory listings

Physical description and handling notes

• Insoluble

How this substance is indexed

Documented uses

• Intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
• Breast Feeding; Lactation; Milk, Human; Enzyme Inhibitors; Phosphodiesterase Inhibitors
• Established Pharmacologic Class [EPC] - Phosphodiesterase 4 Inhibitor
• Mechanisms of Action [MoA] - Phosphodiesterase 4 Inhibitors
• Crisaborole is a Phosphodiesterase 4 Inhibitor. The mechanism of action of crisaborole is as a Phosphodiesterase 4 Inhibitor.
• Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Names this substance appears under

Crisaborole; 906673-24-3; AN-2728; AN2728; Eucrisa; AN 2728; Staquis; crisaborol; Crisaborole topical ointment 2%; 4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile; Q2R47HGR7P; 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile; CHEBI:134677; DTXSID10238231; 4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile; Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-

Computed molecular descriptors

Database abstract

5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole · CAS 906673-24-3 · C14H10BNO3. UNII Q2R47HGR7P.

Source: PubChem / Wikidata; the batch COA governs where values differ.